Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 5,244 | 5,794 | 2,437 | 2,001 | 2,127 |
| Gross Profit | 5,244 | 5,794 | 2,437 | 2,001 | 2,127 |
| Operating Expenses | 55,623 | 43,439 | 56,258 | 55,721 | 59,793 |
| Operating Income | -50,379 | -37,645 | -53,821 | -53,720 | -57,666 |
| Interest Expense | 564 | 524 | 519 | 520 | 358 |
| Other Income | -226 | -494 | 256 | -341 | 1,678 |
| Pre-tax Income | -51,169 | -38,663 | -54,084 | -54,581 | -56,346 |
| Net Income Continuous | -51,169 | -38,663 | -54,084 | -54,581 | -56,346 |
| Net Income | $-51,169 | $-38,663 | $-54,084 | $-54,581 | $-56,346 |
| EPS Basic Total Ops | -1.94 | -1.47 | -2.05 | -2.07 | -2.15 |
| EPS Basic Continuous Ops | -1.94 | -1.47 | -2.05 | -2.07 | -2.15 |
| EPS Diluted Total Ops | -1.94 | -1.47 | -2.05 | -2.07 | -2.15 |
| EPS Diluted Continuous Ops | -1.94 | -1.47 | -2.05 | -2.07 | -2.15 |
| EBITDA(a) | $-50,155 | $-37,335 | $-53,532 | $-53,433 | $-57,359 |